Skip to content

Disc Medicine IRON Operating lease liabilities

Operating lease liabilities at other companies

Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
Beam Therapeutics logo
Beam TherapeuticsBEAM
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's operating lease liabilities?
Disc Medicine (IRON) reported operating lease liabilities of -$168K in Q1 2026.
How has Disc Medicine's operating lease liabilities changed year-over-year?
Disc Medicine's operating lease liabilities decreased by 138.6% year-over-year, from $435K to -$168K.
What is the long-term trend for Disc Medicine's operating lease liabilities?
Over 2 years (2021 to 2024), Disc Medicine's operating lease liabilities has grown at a 87.4% compound annual growth rate (CAGR), from -$141K to -$495K.